What is the clinical evidence from this study?

Study design: Cohort. Population: COVID-19. Intervention: Severe COVID-19 pneumonia.

February 2, 2021Journal of the American Society of EchocardiographyOpen Access

Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study

View Full Paper

Ask AI

Bookmark

Key result

Right ventricular dilation and dysfunction are common in acute severe COVID-19 and are associated with early mortality.

Design

Longitudinal echocardiographic study

Authors

WMWilliam E. MoodyCardiac Imaging BLBoyang LiuUniversity Hospitals Birmingham NHS Foundation Trust HMHani Mahmoud‐ElsayedMagdi Yacoub Heart Foundation

Discussion

Member takes

Implication

RV assessment may refine prognosis in severe COVID-19 with troponin elevation; leaves open whether RV-targeted therapies alter outcomes.

Study Design

Type

Cohort

Structured PICO

Population

COVID-19 survivors who were hospitalized with severe COVID-19 pneumonia and had evidence of myocardial injury based on elevated high-sensitivity cardiac troponin (HScTn)

Outcome

Adverse ventricular remodeling (right ventricular dilation and dysfunction)surrogate

In patients with severe COVID-19 pneumonia, acute right ventricular dilation and dysfunction are highly prevalent and associated with early mortality.

Cite This Study

Moody et al. (2021) conducted a cohort in COVID-19. Severe COVID-19 pneumonia was evaluated. Right ventricular dilation and dysfunction are common in acute severe COVID-19 and are associated with early mortality.

synapsesocial.com/papers/6a7a4aab1b9920df6d893ebf https://doi.org/10.1016/j.echo.2021.01.020

Topics

Echocardiography COVID-19 cardiovascular

View Full Paper

Ask AI

Bookmark